Protocol Ledger

NCT07382167 · Phase III · RECRUITING

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

Interventional Phase III clinical trial protocol NCT07382167 sponsored by Ardelyx in Gastroenterology, Hepatology, and Renal, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-01-13 Enrollment: 692 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07382167
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)692 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07382167
Protocol FieldVerified Registry Value
NCT IdentifierNCT07382167
Consolidated Lead SponsorArdelyx
Therapeutic Condition CohortGastroenterology, Hepatology, and Renal
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment692 participants (ESTIMATED)
Registered Start Date2026-01-13
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI